| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.19B | +7.0% | +21.7% |
| R&D Expense | $2.61B | +1.8% | +7.3% |
| SG&A Expense | $389.0M | -4.9% | -0.3% |
| Operating Income | $5.46B | +15.5% | +25.4% |
| Interest Expense | $1.18B | +11.6% | +32.3% |
| Income Tax | $695.0M | +235.7% | +35.7% |
| Net Income | $3.72B | -39.3% | +26.7% |
| EPS (Basic) | $1.29 | -39.7% | +22.9% |
| EPS (Diluted) | $1.27 | -39.5% | +24.5% |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $38.45B | +99.9% | +120.9% |
| Accounts Receivable | $10.72B | +13.5% | +33.1% |
| Current Assets | $54.87B | +59.7% | +82.2% |
| Total Assets | $245.24B | +19.6% | +52.0% |
| Current Liabilities | $40.74B | +7.8% | +37.5% |
| Stockholders' Equity | $38.49B |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $17.36B | — | — |
| Capital Expenditures | $39.17B | — | — |
| Investing Cash Flow | -$35.98B | — | — |
| Financing Cash Flow | $46.20B | — | — |
| Free Cash Flow | -$21.81B | — | — |
| +130.1% |